Cargando…

Periocular Basal Cell Carcinoma: 20-Years Experience at a Tertiary Eye Care Center of South India

PURPOSE: To study the clinical profile and management outcomes of periocular basal cell carcinoma (BCC). MATERIALS AND METHODS: A retrospective analysis of all histopathologically proven cases of BCC between 1995 and 2015 was done. The demographic data, clinical presentation, histopathological subty...

Descripción completa

Detalles Bibliográficos
Autores principales: Vijay, Vathsalya, Alam, Md. Shahid, Subramanian, Nirmala, Krishnakumar, Subramanian, Biswas, Jyotirmay, Mukherjee, Bipasha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852420/
https://www.ncbi.nlm.nih.gov/pubmed/33542600
http://dx.doi.org/10.4103/ojo.OJO_130_2019
_version_ 1783645818696237056
author Vijay, Vathsalya
Alam, Md. Shahid
Subramanian, Nirmala
Krishnakumar, Subramanian
Biswas, Jyotirmay
Mukherjee, Bipasha
author_facet Vijay, Vathsalya
Alam, Md. Shahid
Subramanian, Nirmala
Krishnakumar, Subramanian
Biswas, Jyotirmay
Mukherjee, Bipasha
author_sort Vijay, Vathsalya
collection PubMed
description PURPOSE: To study the clinical profile and management outcomes of periocular basal cell carcinoma (BCC). MATERIALS AND METHODS: A retrospective analysis of all histopathologically proven cases of BCC between 1995 and 2015 was done. The demographic data, clinical presentation, histopathological subtype, and management outcomes were analyzed. RESULTS: We had a total of 185 malignant eyelid tumors during the study period, out of which 37 (20%) were BCC. Thirty-two (86.5%) out of 37 cases were primary BCC. The mean age was 63.3 years. Pigmented ulcerative lesion (14, 38%), lower eyelid (19, 51%), and nodular BCC (15, 40%) were the most common presentation, periocular site, and histological subtype, respectively. 28 patients underwent excision under frozen section with an average tumor-free margin of 3.5 mm. Mean follow-up period was 18.78 months. Recurrence rate of 0% and 3.1% was noted in primary and recurrent BCC, respectively. CONCLUSION: Periocular BCC commonly presents as pigmented ulcerative lesion in the lower lid. Excision biopsy under frozen section with an average tumor-free margin of 3.5 mm offers cure in most cases.
format Online
Article
Text
id pubmed-7852420
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-78524202021-02-03 Periocular Basal Cell Carcinoma: 20-Years Experience at a Tertiary Eye Care Center of South India Vijay, Vathsalya Alam, Md. Shahid Subramanian, Nirmala Krishnakumar, Subramanian Biswas, Jyotirmay Mukherjee, Bipasha Oman J Ophthalmol Original Article PURPOSE: To study the clinical profile and management outcomes of periocular basal cell carcinoma (BCC). MATERIALS AND METHODS: A retrospective analysis of all histopathologically proven cases of BCC between 1995 and 2015 was done. The demographic data, clinical presentation, histopathological subtype, and management outcomes were analyzed. RESULTS: We had a total of 185 malignant eyelid tumors during the study period, out of which 37 (20%) were BCC. Thirty-two (86.5%) out of 37 cases were primary BCC. The mean age was 63.3 years. Pigmented ulcerative lesion (14, 38%), lower eyelid (19, 51%), and nodular BCC (15, 40%) were the most common presentation, periocular site, and histological subtype, respectively. 28 patients underwent excision under frozen section with an average tumor-free margin of 3.5 mm. Mean follow-up period was 18.78 months. Recurrence rate of 0% and 3.1% was noted in primary and recurrent BCC, respectively. CONCLUSION: Periocular BCC commonly presents as pigmented ulcerative lesion in the lower lid. Excision biopsy under frozen section with an average tumor-free margin of 3.5 mm offers cure in most cases. Wolters Kluwer - Medknow 2020-11-02 /pmc/articles/PMC7852420/ /pubmed/33542600 http://dx.doi.org/10.4103/ojo.OJO_130_2019 Text en Copyright: © 2020 Oman Ophthalmic Society http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Vijay, Vathsalya
Alam, Md. Shahid
Subramanian, Nirmala
Krishnakumar, Subramanian
Biswas, Jyotirmay
Mukherjee, Bipasha
Periocular Basal Cell Carcinoma: 20-Years Experience at a Tertiary Eye Care Center of South India
title Periocular Basal Cell Carcinoma: 20-Years Experience at a Tertiary Eye Care Center of South India
title_full Periocular Basal Cell Carcinoma: 20-Years Experience at a Tertiary Eye Care Center of South India
title_fullStr Periocular Basal Cell Carcinoma: 20-Years Experience at a Tertiary Eye Care Center of South India
title_full_unstemmed Periocular Basal Cell Carcinoma: 20-Years Experience at a Tertiary Eye Care Center of South India
title_short Periocular Basal Cell Carcinoma: 20-Years Experience at a Tertiary Eye Care Center of South India
title_sort periocular basal cell carcinoma: 20-years experience at a tertiary eye care center of south india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852420/
https://www.ncbi.nlm.nih.gov/pubmed/33542600
http://dx.doi.org/10.4103/ojo.OJO_130_2019
work_keys_str_mv AT vijayvathsalya periocularbasalcellcarcinoma20yearsexperienceatatertiaryeyecarecenterofsouthindia
AT alammdshahid periocularbasalcellcarcinoma20yearsexperienceatatertiaryeyecarecenterofsouthindia
AT subramaniannirmala periocularbasalcellcarcinoma20yearsexperienceatatertiaryeyecarecenterofsouthindia
AT krishnakumarsubramanian periocularbasalcellcarcinoma20yearsexperienceatatertiaryeyecarecenterofsouthindia
AT biswasjyotirmay periocularbasalcellcarcinoma20yearsexperienceatatertiaryeyecarecenterofsouthindia
AT mukherjeebipasha periocularbasalcellcarcinoma20yearsexperienceatatertiaryeyecarecenterofsouthindia